Медицина и инновацииМ Сабиров, О Скосырева +12021
COMPARATIVE EVALUATION OF OVULATION INDUCTION AGENTS IN POLYCYSTIC OVARY SYNDROME (PCOS)-RELATED INFERTILITY: A RANDOMIZED CLINICAL TRIAL
Nasiba To'ychiyeva · Sevinch Ravshanova · Zebiniso Allamuratova
Современная наука и исследования · 202-206 · 2025
Аннотация
Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders in reproductive-aged women, affecting 5–20% depending on diagnostic criteria. PCOS is a leading cause of anovulatory infertility and presents with hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology.
Доказательный фрагмент
«Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders in reproductive-aged women, affecting 5–20% depending on diagnostic criteria.»
Образец извлечения
Демо-превьюPolycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders in reproductive-aged women, affecting 5–20% depending on diagnostic criteria. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.
- Цитирований
- 0
- Просмотров
- 0
- Тип
- Журнал
- Страна
- Узбекистан
- Ключевые слова
- To evaluate and compare the ovulation, pregnancy, and live birth rates, as well as adverse effects, associated with Clomiphene Citrate, Letrozole, and gonadotropin therapy in women with PCOS-related infertility.
Смежные источники
Журнал универсальных научных исследованийЭ.Я Эрметов, Д.Э Яхшибоева2024
СтатьиМИРЗАКАРИМОВ Бахромжон Халимжонович, МЕЛИБАЕВ Фарход Абдупаттохович2022
The American Journal of Medical Sciences and Pharmaceutical ResearchMinimally Invasive Surgical Interventions, Mukhammadbobur Makhsitaliev +42020